IGM Biosciences, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
BCEL
Atreca, Inc. |
$0.00 | $3.57 M | -0.04 | 90 |
BDTX
Black Diamond Therapeutics, Inc. |
$1.56 | $88.42 M | -1.23 | 24 |
CERE
Cerevel Therapeutics Holdings, Inc. |
$0.00 | $8.19 B | -16.47 | 355 |
CGEM
Cullinan Oncology, Inc. |
$7.95 | $468.39 M | -2.88 | 111 |
DSGN
Design Therapeutics, Inc. |
$4.06 | $238.40 M | -4.77 | 54 |
ERAS
Erasca, Inc. |
$1.36 | $385.24 M | -1.97 | 103 |
GLUE
Monte Rosa Therapeutics, Inc. |
$5.06 | $312.47 M | -5.18 | 134 |
GRCL
Gracell Biotechnologies Inc. |
$0.00 | $989.87 M | -10.57 | 314 |
HOWL
Werewolf Therapeutics, Inc. |
$0.89 | $41.47 M | -0.57 | 46 |
IKNA
Ikena Oncology, Inc. |
$1.20 | $48.31 M | -1.18 | 10 |
MLYS
Mineralys Therapeutics, Inc. |
$13.18 | $851.18 M | -3.58 | 51 |
PASG
Passage Bio, Inc. |
$0.32 | $20.12 M | -0.3 | 60 |
RNA
Avidity Biosciences, Inc. |
$30.44 | $3.62 B | -10.43 | 391 |
RVMD
Revolution Medicines, Inc. |
$38.38 | $7.13 B | -10.71 | 534 |
STOK
Stoke Therapeutics, Inc. |
$9.74 | $521.58 M | -5.85 | 128 |
TCRR
TCR2 Therapeutics Inc. |
$0.00 | $58.11 M | -0.35 | 58 |
THRX
Theseus Pharmaceuticals, Inc. |
$0.00 | $181.50 M | -3.03 | 38 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
